Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial

OBJECTIVES: We tested cytoplasmic HuR (cHuR) as a predictive marker for response to chemotherapy by examining tumor samples from the international European Study Group of Pancreatic Cancer-3 trial, in which patients with resected pancreatic ductal adenocarcinoma (PDA) received either gemcitabine (GE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg
Main Authors: Tatarian, Talar, Jiang, Wei, Leiby, Benjamin E., Grigoli, Amanda, Jimbo, Masaya, Dabbish, Nooreen, Neoptolemos, John P., Greenhalf, William, Costello, Eithne, Ghaneh, Paula, Halloran, Christopher, Palmer, Daniel, Buchler, Markus, Yeo, Charles J., Winter, Jordan M., Brody, Jonathan R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815674/
https://ncbi.nlm.nih.gov/pubmed/27893535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0000000000002088
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados